PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 32679167-9 2020 Our results showed basal levels of GFAP, S100B, and pro-inflammatory cytokine increased in the epileptic rats but were significantly ameliorated after pretreatment with metformin. Metformin 169-178 glial fibrillary acidic protein Rattus norvegicus 35-39 32779431-10 2020 Metformin decreased the expression of S100b, neuron specific enolase (Nse), and glial fibrillary acidic protein (Gfap). Metformin 0-9 glial fibrillary acidic protein Rattus norvegicus 80-111 32779431-10 2020 Metformin decreased the expression of S100b, neuron specific enolase (Nse), and glial fibrillary acidic protein (Gfap). Metformin 0-9 glial fibrillary acidic protein Rattus norvegicus 113-117 26606013-16 2015 The CCI-induced marked increase of GFAP immunoexpression has been reduced to moderate with fluoxetine (40) and pioglitazone, and to mild with metformin and the combination groups. Metformin 142-151 glial fibrillary acidic protein Rattus norvegicus 35-39 30614910-5 2019 The number of neuronal nuclei positive neuron was significantly increased and glial fibrillary acidic protein positive astrocyte became obviously declined in the CA1 region in I/R rats treated with metformin. Metformin 198-207 glial fibrillary acidic protein Rattus norvegicus 78-109 35386022-11 2022 In the metformin group, there was a reduction in cell apoptosis in the hippocampus, as well as GFAP-positive cells (P < 0.01). Metformin 7-16 glial fibrillary acidic protein Rattus norvegicus 95-99 35103058-14 2022 GFAP level did not change in T2DM but rose in metformin and PA groups vs. control. Metformin 46-55 glial fibrillary acidic protein Rattus norvegicus 0-4 35103058-15 2022 PA+metformin administration diminished GFAP vs. PA. T2DM-induced changes were associated with dramatically decreased ZO-1 levels, while PA treatment increased it almost to control values. Metformin 3-12 glial fibrillary acidic protein Rattus norvegicus 39-43